{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T07:15:05Z","timestamp":1771658105318,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,7,15]],"date-time":"2014-07-15T00:00:00Z","timestamp":1405382400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s12031-014-0377-5","type":"journal-article","created":{"date-parts":[[2014,7,14]],"date-time":"2014-07-14T06:32:58Z","timestamp":1405319578000},"page":"780-786","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Genetic Evidence for the Involvement of Variants at APOE, BIN1, CR1, and PICALM Loci in Risk of Late-Onset Alzheimer\u2019s Disease and Evaluation for Interactions with APOE Genotypes"],"prefix":"10.1007","volume":"54","author":[{"given":"Jalal","family":"Gharesouran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Rezazadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aziz","family":"Khorrami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morteza","family":"Ghojazadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahnaz","family":"Talebi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,15]]},"reference":[{"key":"377_CR1","unstructured":"American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, DC"},{"issue":"5","key":"377_CR2","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2174\/156720511796391926","volume":"8","author":"P Barberger-Gateau","year":"2011","unstructured":"Barberger-Gateau P, Samieri C, Catherine F, Plourde M (2011) Dietary omega 3 polyunsaturated fatty acids and Alzheimer\u2019s disease: interaction with apolipoprotein E genotype. Curr Alzheimer Res 8(5):479\u2013491","journal-title":"Curr Alzheimer Res"},{"key":"377_CR3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1212\/WNL.48.1.139","volume":"48","author":"D Blacker","year":"1997","unstructured":"Blacker D, Haines JL, Rodes L et al (1997) ApoE-4 and age at onset of Alzheimer\u2019s disease: the NIMH genetics initiative. Neurology 48:139\u2013147","journal-title":"Neurology"},{"key":"377_CR4","doi-asserted-by":"crossref","unstructured":"Corneveaux JJ, Myers AJ, Allen AN et al (2010) Association of CR1, CLU and PICALM with Alzheimer\u2019s disease in a cohort of clinically characterized and neuropathologically verified individuals. Hum Mol Genet 19(16):3295\u2013301","DOI":"10.1093\/hmg\/ddq221"},{"key":"377_CR5","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","volume":"63","author":"M Gatz","year":"2006","unstructured":"Gatz M, Reynolds CA, Fratiglioni L, Johansson B, Mortimer JA, Berg S (2006) Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry 63:168\u2013174","journal-title":"Arch Gen Psychiatry"},{"key":"377_CR6","doi-asserted-by":"crossref","unstructured":"Gharesouran J, Rezazadeh M, Ghojazadeh M et al (2013a) Association of CALHM1 gene polymorphism with late onset alzheimer disease. Middle East J Med Genet 2(2):50\u201354","DOI":"10.1097\/01.MXE.0000430777.29752.3a"},{"key":"377_CR7","doi-asserted-by":"crossref","unstructured":"Gharesouran J, Rezazadeh M, Mohaddes Ardebili SM M et al (2013b) Investigation of five polymorphic DNA markers associated with late onset alzheimer disease. Genetika 45(2):503\u2013514","DOI":"10.2298\/GENSR1302503G"},{"key":"377_CR8","doi-asserted-by":"crossref","unstructured":"Goate A, Chartier-Harlin MC, Mullan M, Brown J et al (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer\u2019s disease. Nature 349:704\u2013706","DOI":"10.1038\/349704a0"},{"key":"377_CR9","first-page":"1","volume":"39","author":"E Gozalpour","year":"2010","unstructured":"Gozalpour E, Kamali K, Mohammd K et al (2010) Association between Alzheimer\u2019s disease and apolipoprotein E polymorphisms. Iran J Publ Health 39:1\u20136","journal-title":"Iran J Publ Health"},{"issue":"12","key":"377_CR10","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/archneurol.2010.201","volume":"67","author":"J Gyungah","year":"2010","unstructured":"Gyungah J, Adam CN, Gary WB (2010) Meta-analysis confirms CR1, CLU, and PICALM as Alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol 67(12):1473\u20131484","journal-title":"Arch Neurol"},{"key":"377_CR11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1600-0854.2007.00694.x","volume":"9","author":"A Harel","year":"2008","unstructured":"Harel A, Wu F, Mattson MP, Morris CM, Yao PJ (2008) Evidence for CALM in directing VAMP2 trafficking. Traffic 9:417\u2013429","journal-title":"Traffic"},{"issue":"10","key":"377_CR12","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold D, Abraham R, Hollingworth P et al (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease, and shows evidence for additional susceptibility genes. Nat Genet 41(10):1088\u20131093","journal-title":"Nat Genet"},{"issue":"2","key":"377_CR13","doi-asserted-by":"crossref","first-page":"e54483","DOI":"10.1371\/journal.pone.0054483","volume":"8","author":"AC Hostage","year":"2013","unstructured":"Hostage AC, Choudhury K, Doraiswamy PM et al (2013) Dissecting the gene dose-effects of the APOE e4 and e2 alleles on hippocampal volumes in aging and Alzheimer\u2019s disease. PLoS ONE 8(2):e54483","journal-title":"PLoS ONE"},{"issue":"2","key":"377_CR14","doi-asserted-by":"crossref","first-page":"e16616","DOI":"10.1371\/journal.pone.0016616","volume":"6","author":"X Hu","year":"2011","unstructured":"Hu X, Pickering E, Liu CY et al (2011) Meta-analysis for genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer\u2019s disease. PLoS ONE 6(2):e16616","journal-title":"PLoS ONE"},{"key":"377_CR15","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.bbalip.2010.04.005","volume":"1801","author":"L Jones","year":"2010","unstructured":"Jones L, Harold D, Williams J (2010) Genetic evidence for the involvement of lipid metabolism in Alzheimer\u2019s disease. Biochim Biophys Acta 1801:754\u2013761","journal-title":"Biochim Biophys Acta"},{"key":"377_CR16","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/archneurol.2010.201","volume":"67","author":"G Jun","year":"2010","unstructured":"Jun G, Naj AC, Beecham GW, Wang L et al (2010) Meta-analysis confirms CR1, CLU, and PICALM as Alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol 67:1473\u20131484","journal-title":"Arch Neurol"},{"issue":"3","key":"377_CR17","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.neurobiolaging.2010.04.015","volume":"33","author":"MI Kamboh","year":"2012","unstructured":"Kamboh MI, Minster RL, Demirci FY (2012a) Association of CLU and PICALM variants with Alzheimer\u2019s disease. Neurobiol Aging 33(3):518\u2013521","journal-title":"Neurobiol Aging"},{"key":"377_CR18","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1038\/tp.2012.45","volume":"2","author":"MI Kamboh","year":"2012","unstructured":"Kamboh MI, Demirci FY, Wang X et al (2012b) Genome-wide association study of Alzheimer\u2019s disease. Transl Psychiatry 2:e117","journal-title":"Transl Psychiatry"},{"issue":"5","key":"377_CR19","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.molimm.2008.09.026","volume":"46","author":"R Khera","year":"2009","unstructured":"Khera R, Das N (2009) Complement receptor 1: disease associations and therapeutic implications. Mol Immunol 46(5):761\u2013772","journal-title":"Mol Immunol"},{"issue":"4","key":"377_CR20","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1582-4934.2008.00557.x","volume":"13","author":"J Koren","year":"2009","unstructured":"Koren J, Jinwal UK et al (2009) Chaperone signalling complexes in Alzheimer\u2019s disease. J Cell Mol Med 13(4):619\u2013630","journal-title":"J Cell Mol Med"},{"key":"377_CR21","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1034\/j.1600-065X.2001.1800110.x","volume":"180","author":"M Krych-Goldberg","year":"2001","unstructured":"Krych-Goldberg M, Atkinson JP (2001) Structure\u2013function relationships of complement receptor type 1. Immunol Rev 180:112\u2013122","journal-title":"Immunol Rev"},{"issue":"6955","key":"377_CR22","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/bmj.309.6955.636","volume":"309","author":"J Kuusisto","year":"1994","unstructured":"Kuusisto J, Koivisto K, Kervinen K et al (1994) Association of apolipoprotein E phenotypes with late onset Alzheimer\u2019s disease: population based study. BMJ 309(6955):636\u2013638","journal-title":"BMJ"},{"issue":"5","key":"377_CR23","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2217\/epi.10.43","volume":"2","author":"JB Kwok","year":"2010","unstructured":"Kwok JB (2010) Role of epigenetics in Alzheimer\u2019s and Parkinson\u2019s disease. Epigenomics 2(5):671\u2013682","journal-title":"Epigenomics"},{"key":"377_CR24","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","volume":"41","author":"JC Lambert","year":"2009","unstructured":"Lambert JC, Heath S, Even G et al (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease. Nat Genet 41:1094\u20131099","journal-title":"Nat Genet"},{"issue":"4","key":"377_CR25","doi-asserted-by":"crossref","first-page":"756.e11","DOI":"10.1016\/j.neurobiolaging.2010.11.022","volume":"32","author":"JC Lambert","year":"2011","unstructured":"Lambert JC, Zelenika D, Hiltunen M et al (2011) Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations. Neurobiol Aging 32(4):756.e11\u20135","journal-title":"Neurobiol Aging"},{"key":"377_CR26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1741-7015-10-127","volume":"10","author":"MJ Lazarczyk","year":"2012","unstructured":"Lazarczyk MJ, Hof PR, Bouras C, Giannakopoulos P (2012) Preclinical Alzheimer disease: identification of cases at risk among cognitively intact older individuals. BMC Med 10:127","journal-title":"BMC Med"},{"issue":"3","key":"377_CR27","first-page":"320","volume":"68","author":"JH Lee","year":"2011","unstructured":"Lee JH, Cheng R, Barral S et al (2011) Identification of novel loci for Alzheimer disease and replication of CLU, PICALM, and BIN1 in Caribbean Hispanic individuals. Arch Neurol 68(3):320\u2013328","journal-title":"Arch Neurol"},{"key":"377_CR28","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.3283935","volume":"240","author":"RW Mahley","year":"1988","unstructured":"Mahley RW, Rall SC (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240:622\u2013630","journal-title":"Science"},{"issue":"2","key":"377_CR29","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.gene.2012.08.026","volume":"512","author":"TA Masoodi","year":"2013","unstructured":"Masoodi TA, Al Shammari SA, Al-Muammar MN, Alhamdan AA, Talluri VR (2013) Exploration of deleterious single nucleotide polymorphisms in late-onset Alzheimer disease susceptibility genes. Gene 512(2):429\u2013437","journal-title":"Gene"},{"key":"377_CR30","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S1474-4422(05)70168-X","volume":"4","author":"C Mei Sian","year":"2005","unstructured":"Mei Sian C, Sahadevan S (2005) Preclinical Alzheimer\u2019s disease: diagnosis and prediction of progression. Lancet Neurol 4:576\u2013579","journal-title":"Lancet Neurol"},{"key":"377_CR31","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ng.801","volume":"43","author":"AC Naj","year":"2011","unstructured":"Naj AC, Jun G, Beecham GW (2011) Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer\u2019s disease. Nat Genet 43:436\u2013441","journal-title":"Nat Genet"},{"key":"377_CR32","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/YPG.0b013e3283586215","volume":"22","author":"T Ohara","year":"2012","unstructured":"Ohara T, Ninomiya T, Hirakawa Y et al (2012) Association study of susceptibility genes for late-onset Alzheimer\u2019s disease in the Japanese population. Psychiatr Genet 22:290\u2013293","journal-title":"Psychiatr Genet"},{"key":"377_CR33","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","volume":"362","author":"HW Querfurth","year":"2010","unstructured":"Querfurth HW, LaFerla FM (2010) Alzheimer\u2019s disease. N Engl J Med 362:329\u2013344","journal-title":"N Engl J Med"},{"issue":"3","key":"377_CR34","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3174\/ajnr.A3545","volume":"35","author":"AT Rao","year":"2014","unstructured":"Rao AT, Degnan AJ, Levy LM (2014) Genetics of Alzheimer disease. AJNR Am J Neuroradiol 35(3):457\u2013458","journal-title":"AJNR Am J Neuroradiol"},{"issue":"11","key":"377_CR35","first-page":"1558","volume":"35","author":"EI Rogaev","year":"1999","unstructured":"Rogaev EI (1999) Genetic factors and a polygenic model of Alzheimer\u2019s disease. Genetika 35(11):1558\u20131571","journal-title":"Genetika"},{"key":"377_CR36","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/376775a0","volume":"376","author":"EI Rogaev","year":"1995","unstructured":"Rogaev EI, Sherrington R, Rogaeva EA et al (1995) Familial Alzheimer\u2019s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer\u2019s disease type 3 gene. Nature 376:775\u2013778","journal-title":"Nature"},{"key":"377_CR37","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev.med.47.1.387","volume":"47","author":"AD Roses","year":"1996","unstructured":"Roses AD (1996) Apolipoprotein E alleles as risk factors in Alzheimer\u2019s disease. Annu Rev Med 47:387\u2013400","journal-title":"Annu Rev Med"},{"key":"377_CR38","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","volume":"43","author":"AM Saunders","year":"1993","unstructured":"Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop et al (1993) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer\u2019s disease. Neurology 43:1467\u20131472","journal-title":"Neurology"},{"key":"377_CR39","doi-asserted-by":"crossref","first-page":"9649","DOI":"10.1073\/pnas.90.20.9649","volume":"90","author":"DE Schmechel","year":"1993","unstructured":"Schmechel DE, Saunders AM, Strittmatter WJ et al (1993) Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci 90:9649\u20139653","journal-title":"Proc Natl Acad Sci"},{"issue":"18","key":"377_CR40","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1001\/jama.2010.574","volume":"303","author":"S Seshadri","year":"2010","unstructured":"Seshadri S, Fitzpatrick AL, Ikram MA et al (2010) Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 303(18):1832\u20131840","journal-title":"JAMA"},{"key":"377_CR41","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/375754a0","volume":"375","author":"R Sherrington","year":"1995","unstructured":"Sherrington R, Rogaev EI, Liang Y et al (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer\u2019s disease. Nature 375:754\u2013760","journal-title":"Nature"},{"issue":"8","key":"377_CR42","doi-asserted-by":"crossref","first-page":"1849e5","DOI":"10.1016\/j.neurobiolaging.2012.02.014","volume":"33","author":"H Shi","year":"2012","unstructured":"Shi H, Belbin O, Medway C et al (2012) Genetic variants influencing human aging from late-onset Alzheimer\u2019s disease (LOAD) genome-wide association studies (GWAS). Neurobiol Aging 33(8):1849e5\u20131849e18","journal-title":"Neurobiol Aging"},{"key":"377_CR43","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1385\/JMN:23:3:157","volume":"23","author":"JW Stanford","year":"2004","unstructured":"Stanford JW (2004) APOE genotype effects on Alzheimer\u2019s disease onset and epidemiology. J Mol Neurosci 23:157\u2013165","journal-title":"J Mol Neurosci"},{"key":"377_CR44","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter WJ, Saunders AM, Schmechel D,\u00a0Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci 90:1977\u20131981","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"377_CR45","first-page":"249","volume":"46","author":"M Styczy\u00f1ska","year":"2008","unstructured":"Styczy\u00f1ska M, Strosznajder JB, Religa D et al (2008) Association between genetic and environmental factors and the risk of Alzheimer\u2019s disease. Folia Neuropathol 46(4):249\u2013254","journal-title":"Folia Neuropathol"},{"issue":"5","key":"377_CR46","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jalz.2012.08.007","volume":"9","author":"JT Tan","year":"2012","unstructured":"Tan JT, Yu W, Zhang ZC et al (2012) Association of GWAS-linked loci with late-onset Alzheimer\u2019s disease in a northern Han Chinese population. Alzheimers Dement 9(5):546\u2013553","journal-title":"Alzheimers Dement"},{"issue":"10","key":"377_CR47","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.molmed.2013.06.004","volume":"19","author":"MS Tan","year":"2013","unstructured":"Tan MS, Yu JT, Tan L (2013) Bridging integrator 1 (BIN1): form, function, and Alzheimer\u2019s disease. Trends Mol Med 19(10):594\u2013603","journal-title":"Trends Mol Med"},{"key":"377_CR48","doi-asserted-by":"crossref","unstructured":"Tebar F, Bohlander SK, Sorkin A (1999) Clathrin assembly lymphoid myeloid leukemia (CALM) protein: localization in endocytic-coated pits, interactions with clathrin, and the impact of overexpression on clathrin-mediated traffic. Mol Biol Cell 10:2687\u20132702","DOI":"10.1091\/mbc.10.8.2687"},{"key":"377_CR49","doi-asserted-by":"crossref","unstructured":"The Dementia Study Group of the Italian Neurological Society (2000) Guidelinesfor the diagnosis of dementia and Alzheimer\u2019s disease. Ital J Neurol Sci 21:187\u2013194","DOI":"10.1007\/s100720070075"},{"issue":"3","key":"377_CR50","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3233\/JAD-2010-091606","volume":"20","author":"IA Rossum van","year":"2010","unstructured":"van Rossum IA, Vos S, Handels R, Visser PJ (2010) Biomarkers as predictors for conversion from mild cognitive impairment to Alzheimer-type dementia implications for trial design. J Alzheimers Dis 20(3):881\u2013891","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"377_CR51","doi-asserted-by":"crossref","first-page":"e1001308","DOI":"10.1371\/journal.pgen.1001308","volume":"7","author":"EW Wijsman","year":"2011","unstructured":"Wijsman EW, Nathan DP, Yoonha C et al (2011) Genome-wide association of familial late-onset Alzheimer\u2019s disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE. PLoS Genet 7(2):e1001308","journal-title":"PLoS Genet"},{"issue":"9","key":"377_CR52","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.freeradbiomed.2009.02.006","volume":"46","author":"N Zawia","year":"2009","unstructured":"Zawia N, Lahiri DK, Cardozo-Pelaez F (2009) Epigenetics, oxidative stress and Alzheimer\u2019s disease. Free Radic Biol Med 46(9):1241\u20131249","journal-title":"Free Radic Biol Med"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-014-0377-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12031-014-0377-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-014-0377-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T15:30:56Z","timestamp":1565623856000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12031-014-0377-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,15]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["377"],"URL":"https:\/\/doi.org\/10.1007\/s12031-014-0377-5","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,15]]}}}